Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$3.72M$3.72Mderived+15.7% vs Q4 2019 Net Income-$1.58M-$1.58MderivedN/M vs Q4 2019 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$2,264,000N/M Operating Cash Flowderived-$2,401,000N/M Margins · derivedOperating margin-60.9%−16.8 pt vs Q4 2019
Net margin-42.6%+8.7 pt vs Q4 2019
ended Dec 31, 2020 · filed Mar 22, 2021 · 81 d after period end